Disclosures for "Investigating Metabotropic Glutamate Receptor 5 (mGluR5) in Autism Spectrum Disorder with [18F]FPEB PET Imaging"
-
Mr. Ebrahimian Saadabad has nothing to disclose.
-
Ms. Yang has nothing to disclose.
-
Dr. Gravel has nothing to disclose.
-
Dr. Naples has nothing to disclose.
-
Mrs. Torres has nothing to disclose.
-
Nabeel Nabulsi, 21953 has nothing to disclose.
-
Dr. Ropchan has nothing to disclose.
-
An immediate family member of Yiyun Huang, 8202 has stock in Pfiy. An immediate family member of Yiyun Huang, 8202 has stock in Johnson and Johnson . Yiyun Huang, 8202 has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
-
Dr. Hillmer has nothing to disclose.
-
Dr. Esterlis has nothing to disclose.
-
The institution of Prof. E Carson has received research support from Invicro. The institution of Prof. E Carson has received research support from BMS. The institution of Prof. E Carson has received research support from Pfizer. The institution of Prof. E Carson has received research support from Cerevel.
-
Dr. McPartland has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Modern Clinics. Dr. McPartland has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Lawyer. The institution of Dr. McPartland has received research support from NIH. Dr. McPartland has received publishing royalties from a publication relating to health care.
-
Dr. Matuskey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Eleisver. The institution of Dr. Matuskey has received research support from Abbvie.